FdaApplication

NDA 207958

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAPRECIA PHARMACEUTICALS LLC
application_typeNDA
approval_date2015-07-31

Products (4)

ProductActive ingredientStrengthDosage form
SPRITAMLEVETIRACETAM500MGTABLET, FOR SUSPENSION;ORAL
SPRITAMLEVETIRACETAM250MGTABLET, FOR SUSPENSION;ORAL
SPRITAMLEVETIRACETAM1GMTABLET, FOR SUSPENSION;ORAL
SPRITAMLEVETIRACETAM750MGTABLET, FOR SUSPENSION;ORAL

4 products